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hink about the last time you
felt stressed. Did your heart
beat faster? Did your stomach tie into knots? Maybe your
hands went cold, or possibly started shaking? The brain is in control
of all of these physiological changes, and is actually trying to help
you survive what it interprets as a
potentially life-threatening situation. It’s commonly thought of as
the fight-or-flight response; either
your body prepares to run away
from the problem or readies itself
to stay and tackle the threat.
The pathway in charge of
this response is known as the hypothalamic-pituitary-adrenal axis,
or the HPA axis for short (see
Figure 1). It is so important for
survival that it has been conserved
by evolution, appearing in some
form in even the earliest of vertebrate species (Denver, 2009). The
HPA axis consists of a complicated
series of steps that begin in the hypothalamus, where a specific group
of cells secrete corticotropin-releasing hormone. This hormone

is then able to travel through the
brain to reach the pituitary, which
is the pea-sized gland sitting just
behind the bridge of the nose.
Once the corticotropin-releasing
hormone interacts with this gland,
it stimulates the release of adrenocorticotropic hormone. Because
of the location of the pituitary, adrenocorticotropic hormone is able
to be transported throughout the
body until it eventually finds cells
on the adrenal cortex with which it
can interact. This hormone works
to stimulate the production of the
steroid hormone cortisol. Once
cortisol enters the bloodstream, it
has significant effects all over the
body.
The Many Roles of Cortisol
Cortisol greatly impacts both metabolism and digestion. Specifically, it is associated with glucose,
the sugar that converts into every
cell’s energy supply known as adenosine triphosphate. Cortisol,
by influencing gene transcription,

stimulates gluconeogenesis, which
is the process of forming glucose
from precursors other than carbohydrates, during periods of fasting
(Khani & Tayek, 2001). This response allows the liver to use glucose that the peripheral tissue does
not need and converts it into liver
glycogen, thus preparing the body
should it encounter a food shortage and starvation (Barcellos et al.,
2010). In addition, cortisol plays
an important, though indirect, role
in both liver and muscle glycogenolysis, which is the breakdown
of glycogen once the body needs
to use its stored glucose (Barcellos
et al., 2010; Coderre et al., 1991).
Cortisol is able to do this by influencing and interacting with glucagon, the hormone that regulates
the usage of glucose (Lecavalier et
al., 1990). Because of the many
interactions between cortisol and
glucose, researchers believed and
have, ultimately, demonstrated
that HPA axis activity is enhanced
in many patients with diabetes
(Chiodini et al., 2015).
Besides affecting glucose
processes, cortisol influences electrolyte balance. Cortisol is a diuretic, preventing cells from losing

Did You Know?
Some scientists believe that cortisol’s
original purpose may have been
sodium transport. They have found
that freshwater fish use a cortisol-based system to bring sodium in,
whereas saltwater fish use it to expel
extra salt (Laurent & Perry, 1990;
Maetz et al., 1967).
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sodium as well as promotes potassium excretion, thus helping to
regulate bodily pH (Knight et al.,
1955). Maintaining a pH between
6.0 and 7.5 is important because
of the negative consequences of
having too much acid, known as
metabolic acidosis, or bicarbonate,
known as alkalosis, in the blood,
which range from muscle twitches
to lung collapse (Arruda & Kurtzman, 1977).
Cortisol also affects the
immune system. It prevents the
release of substances that cause
inflammation, such as IL-12,
interferon, IFN-gamma, and
TNF-alpha, by antigen-presenting cells and Th1 cells, while also
upregulating anti-inflammatory
substances, such as IL-4, IL-10,
and IL-13, by Th2 cells (Elenkov,
2004; Franchimont, 2004). Because of these effects, cortisol is
often used to treat conditions such
as rheumatoid arthritis, vasculitis,
lupus, and allergies, as well as skin
problems like rashes and eczema
(Vane & Botting, 1987).
Circadian rhythm is also
greatly impacted by cortisol. Normal cortisol secretion, meaning
when it is not induced by the activation of the HPA axis, undergoes diurnal variation: the levels

peak around 8:00am and bottom
out around midnight (Chung et
al., 2011). This pattern contrasts
that of melatonin secretion, with
melatonin being the hormone responsible for regulating sleepiness
and wakefulness. In the morning, melatonin levels are low, and
eventually rise at night once the
brain’s pineal gland is activated by
the hypothalamus (Monteleone et
al., 1992). Researchers have found
that cortisol and melatonin actually work to counteract each other,
with a high concentration of one
inhibiting the activity of the other
(Monteleone et al., 1992; Zisapel
et al., 2005).
Finally, cortisol works to
inhibit the further production of
itself in a negative feedback loop
(see Figure 2). The presence of
high concentrations of the hormone within the bloodstream inhibit the release of both more corticotropin-releasing hormone and
more adrenocorticotropic hormone (Gold et al., 2002; Wood
& Rudolph, 1983). There are
similar points of negative feedback
along the HPA axis, namely how
high concentrations of adrenocorticotropic hormone prevents the
secretion of additional corticotropin-releasing hormone (Abelson

Figure 2 Here, you can see the many negative feedback loops (pictured in pink) involved in the HPA axis. Created by Christina Ennis.
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et al., 2007; Yehuda et al., 2006).
These loops exist because of the
dangers associated with high levels of cortisol, and actively work
to ensure that these levels are not
reached.
Stress and Development
Researchers have found that prenatal stress can influence HPA
axis regulation after birth and later in life. In animal experiments,
exposure to prenatal stress causes a hyperreactivity of the HPA
axis. Prenatally stressed rats, for
example, have higher basal levels
of corticosterone, their version of
cortisol, as well as abnormal circadian rhythms (Koehl et al., 1999).
They also require a longer period of
time after the presence of a stressor
for their hormone levels to return
to their baseline. Other studies
have demonstrated that prenatally
stressed animals have high blood
glucose levels, as well as have fewer
glucocorticoid receptors in some
areas of the brain (Weinstock et al.,
1992). Switching over to human
studies, there is growing evidence
that prenatal stress impacts HPA
axis regulation. Children that
were stressed prenatally have been
shown exhibit abnormal cortisol
rhythms (Glover et al., 2010; Gutteling et al., 2005). Additionally,
prolonged maternal stress is associated with mild impairments of
intellectual activity and language
development in their children,
and is linked to disorders such as
attention deficit hyperactivity disorder, schizophrenia, anxiety, and
depression (Weinstock, 2008).
However, the effect of early
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life stress on HPA axis functioning
is less understood. Differing levels
of stress seem to have opposing effects later in life: exposure to mild
or moderate stressors early in life
enhance HPA regulation whereas
early-life exposure to extreme or
prolonged stress can induce hyperreactivity of the HPA axis and thus
contributes to a lifelong vulnerability to stress (Flinn et al., 2011;
Liu et al., 1997). Several mechanisms have been proposed to explain these conflicting impacts of
stress. Some believe that there is
a critical period of development in
which the levels of stress hormones
within the bloodstream permanently calibrate the functioning of
the HPA axis (Champagne et al.,
2003; Macrì & Würbel, 2006).
Others, however, hypothesize that
such effects are mediated by maternal care, either through inducing
epigenetic changes or promoting a
sense of calmness in the offspring
(Champagne et al., 2003; de
Kloet et al., 2005; Schechter et al.,
2015). Whatever the cause, prolonged early life stress is thought
to sensitize the HPA axis, thus resulting in the hypersecretion of the
various hormones involved in the
pathway. This aspect of sensitization is supported by the findings
that adulthood victims of childhood abuse have increased concentrations of adrenocorticotropic
hormone and corticotropin-releasing hormone after exposure
to a psychosocially stressful event
(Heim et al., 2001).
Hyperactivity of the HPA Axis
You may be wondering why

Did You Know?
Yoga and meditation have proved to be effective techniques in reducing stress and regulating HPA axis stimulation. It also triggers alpha brain wave activity, which
is thought to promote relaxation and creativity while
minimizing depression (Kamei et al., 2000).

non-life-threatening events, such
as a meeting with a boss or a final
exam, are able to trigger the activation of the HPA axis, and thus
the production of cortisol, in some
people. In the face of periods of severe stress during adulthood, such
as those caused by negative work
or family relationships or combat
exposure for example, the dynamics of the HPA axis change (Stephens & Wand, 2012). Specifically, chronic stress triggers a shift in
the normal diurnal release of cortisol as well as in the stress-induced
levels of this hormone (Juster et
al., 2011; McEwen, 2007; Stephens & Wand, 2012). In short,
this means that chronic stress increases the baseline levels of cortisol in the body while also increasing the sensitivity of the HPA axis,
resulting in its activation during
times where typically it would and
should not be. It is here, when
the HPA axis is inappropriately or
persistently activated, where problems start to arise.
Clearly, the hyperactivity
of the HPA axis has a role in anxiety disorders. Anxiety disorders,
including generalized anxiety disorder, obsessive-compulsive disorder, panic disorder, posttraumatic
stress disorder, and social phobias,
are the most common psychiatric
illnesses, affecting up to 33.7% of

the population (Bandelow & Michaelis, 2015). Often, these maladies are treated with drugs such as
selective serotonin-reuptake inhibitors and benzodiazepines, which
work by altering the levels of neurotransmitters able to interact with
brain cells. However, researchers
have identified a secondary action
of these drugs: they correct HPA
axis hypersensitivity (Lenze et al.,
2011; Lopez et al., 1990). These
findings are significant because the
process of directly assessing HPA
axis functioning is difficult and
complex. Since this pathway is
activated during stress, measuring
cortisol levels in the bloodstream
after exposure to various triggers
would be too specific to each individual since not everyone has the
same reaction to the same stimuli, if not cruel to all of the participants of the study. Therefore, the
ability to study HPA axis dysfunctioning in patients with anxiety
disorders through their treatment
plans is optimal.
In addition, the HPA axis
has been shown to dysfunction
during psychotic episodes. One
model of psychosis posits that predisposing biological factors make
some individuals more sensitive
to stress, and thus more vulnerable to developing psychosis after
stressful events (Mondelli et al.,
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with autoimmune disorders. The
treatment options for this disease
are limited, with surgeries resulting in complete remission in 60%
of cases (Sharma et al., 2015).

Did You Know?
Caffeine stimulates the release of
cortisol. However, if you consume
moderate levels of caffeine, meaning
300 mg, or three cups of brewed
coffee, daily, then cortisol secretion
is less than if you do not (Lovallo et
al., 2008).
2010). Following this assumption,
first-episode psychosis patients display HPA axis hyperactivity and
high basal levels of cortisol, acting
as both a causal and exacerbating
factor of their clinical symptoms
as well as cognitive impairments
(Gallagher et al., 2007; Herz et
al., 1985; Lammers et al., 1995;
Sachar et al., 1970; Tandon et al.,
1991). However, some theorize
that this hyperactivity contributes
to the pathogenesis of psychotic
disorders by increasing brain dopaminergic activity (Mondelli et al.,
2010; Walker & Diforio, 1997).
This idea is supported by the fact
that antipsychotic drugs, in addition to regulating dopamine levels, have a secondary function of
lowering HPA axis activity (Cohrs
et al., 2006; Lammers et al., 1995;
Mondelli et al., 2010).
HPA dysregulation has
been identified in many other
mental health disorders. In particular, depression has been extensively studied as cortisol has a
multifaceted role in its symptomatology. In over half of the cases
of major depression, the diurnal
rhythms of this hormone is disturbed and the negative feedback
loops that prevent its accumulation are nonfunctional (Burke et
al., 2005; Herbert, 2012). Addi-
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Hypoactivity of the HPA Axis
“Coffee” by Julius Schorzman” is
licensed by CC BY-SA 2.0.

tionally, patients with major depression have been shown to have
significantly higher levels of cortisol than in those with either panic
disorder and schizophrenia (Yehuda et al., 1993). It is thought
that cortisol contributes to major
depression by altering the volume
and metabolism of various brain
regions, including the prefrontal cortex, the amygdala, and the
hippocampus (Gold et al., 2002).
Interestingly, cortisol has been
shown to activate the genetic basis of major depression in the same
way as environment events amplify the risk of this disorder, with its
influence beginning prenatally but
continuing into adulthood (Herbert, 2012).
However, there is a disease
in which cortisol hypersecretion
is present without a hypersensitivity of the HPA axis: Cushing’s
syndrome. This disease, though
rare since it affects on average only
one person per million per year,
can have devastating effects on the
health of those affected by it (Sharma et al., 2015). Cushing’s syndrome is usually caused by a tumor
somewhere along the HPA axis,
such as on the pituitary or adrenal
glands, or is induced by high levels
of exogenous glucocorticoid exposure, as is the case in some patients

At this point, you may be thinking that cortisol is a dangerous
hormone, and that less of it would
lead to a healthier and happier
life. However, this is not always
the case. There is a life-threatening disease, known as adrenal insufficiency or Addison’s disease, in
which the adrenal glands do not
function properly, resulting in the
body producing too little cortisol.
Affecting only 100 people per million, it impairs quality of life by
causing problems with circadian
rhythm, weight loss, low blood
pressure and sugar, as well as triggering stomach issues (Bensing et
al., 2016).
Just as in hyperactivity,
there are also disorders in which
the HPA axis is abnormally inactive. Perhaps the most common of
these is chronic fatigue syndrome,
as it affects nearly 5% of the population (Johnston et al., 2013). Researchers have demonstrated that
the HPA axis in patients with this
disease have low basal evening levels of cortisol, yet high basal evening levels of adrenocorticotropic
hormone, and even hypothesize
that the disease is in fact caused by
problems in this pathway (Demitrack et al., 1991).
The Bottom Line
Clearly, the HPA axis has a signif-
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icant impact on multiple aspects
of both physiological and mental
health. Though cortisol gets a bad
reputation, with multiple vitamin
and drug companies claiming that
it is at the root of any issue you may
encounter, this is not true. It is
only in the presence of chronically
high or low levels of this stress hormone where such problems arise.
However, that does not mean to
say that stressful periods are in
isolation healthy. While they are
necessary for both motivation and
even survival, times of stress can
result in discomfort and ultimately
lead to the development of various
disorders, including anxiety and
depression. So, the next time you
notice that you’re feeling stressed,
take into account the processes going on within your body and the
damage you may be causing if you
let stressors affect you too much.
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